169 related articles for article (PubMed ID: 25703954)
1. Nanoparticles for controlled delivery and sustained release of chlorhexidine in the oral environment.
Garner S; Barbour ME
Oral Dis; 2015 Jul; 21(5):641-4. PubMed ID: 25703954
[TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine hexametaphosphate nanoparticles as a novel antimicrobial coating for dental implants.
Wood NJ; Jenkinson HF; Davis SA; Mann S; O'Sullivan DJ; Barbour ME
J Mater Sci Mater Med; 2015 Jun; 26(6):201. PubMed ID: 26123234
[TBL] [Abstract][Full Text] [Related]
3. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products.
Barbour ME; Maddocks SE; Wood NJ; Collins AM
Int J Nanomedicine; 2013; 8():3507-19. PubMed ID: 24092973
[TBL] [Abstract][Full Text] [Related]
5. Concentration dependent aggregation properties of chlorhexidine salts.
Zeng P; Zhang G; Rao A; Bowles W; Wiedmann TS
Int J Pharm; 2009 Feb; 367(1-2):73-8. PubMed ID: 18926892
[TBL] [Abstract][Full Text] [Related]
6. Transient reduction of mutans streptococci on tooth surfaces using a chlorhexidine-containing glass ionomer cement varnish.
Hoszek A; Ericson D
Swed Dent J; 1999; 23(2-3):97-105. PubMed ID: 10431345
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel antimicrobial-releasing glass ionomer cement functionalized with chlorhexidine hexametaphosphate nanoparticles.
Hook ER; Owen OJ; Bellis CA; Holder JA; O'Sullivan DJ; Barbour ME
J Nanobiotechnology; 2014 Jan; 12():3. PubMed ID: 24456793
[TBL] [Abstract][Full Text] [Related]
8. Glass ionomer cements with milled, dry chlorhexidine hexametaphosphate filler particles to provide long-term antimicrobial properties with recharge capacity.
Bellis CA; Addison O; Nobbs AH; Duckworth PF; Holder JA; Barbour ME
Dent Mater; 2018 Dec; 34(12):1717-1726. PubMed ID: 30249499
[TBL] [Abstract][Full Text] [Related]
9. Adsorption of chlorhexidine on synthetic hydroxyapatite and in vitro biological activity.
de Souza CA; Colombo AP; Souto RM; Silva-Boghossian CM; Granjeiro JM; Alves GG; Rossi AM; Rocha-Leão MH
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):310-8. PubMed ID: 21676601
[TBL] [Abstract][Full Text] [Related]
10. An antifungal coating for dental silicones composed of chlorhexidine nanoparticles.
Garner SJ; Nobbs AH; McNally LM; Barbour ME
J Dent; 2015 Mar; 43(3):362-72. PubMed ID: 25511302
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial substantivity of bovine root dentin exposed to different chlorhexidine delivery vehicles.
Lenet BJ; Komorowski R; Wu XY; Huang J; Grad H; Lawrence HP; Friedman S
J Endod; 2000 Nov; 26(11):652-5. PubMed ID: 11469294
[TBL] [Abstract][Full Text] [Related]
12. Functionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles.
Wood NJ; Maddocks SE; Grady HJ; Collins AM; Barbour ME
Int J Nanomedicine; 2014; 9():4145-52. PubMed ID: 25206305
[TBL] [Abstract][Full Text] [Related]
13. [Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial].
Koeman M; van der Ven AJ; Hak E; Joore JC; Kaasjager HA; de Smet AM; Ramsay G; Dormans TP; Aarts LP; de Bel EE; Hustinx WN; van der Tweel I; Hoepelman IM; Bonten MJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(13):752-9. PubMed ID: 18461894
[TBL] [Abstract][Full Text] [Related]
14. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia.
Koeman M; van der Ven AJ; Hak E; Joore HC; Kaasjager K; de Smet AG; Ramsay G; Dormans TP; Aarts LP; de Bel EE; Hustinx WN; van der Tweel I; Hoepelman AM; Bonten MJ
Am J Respir Crit Care Med; 2006 Jun; 173(12):1348-55. PubMed ID: 16603609
[TBL] [Abstract][Full Text] [Related]
15. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate.
Lboutounne H; Chaulet JF; Ploton C; Falson F; Pirot F
J Control Release; 2002 Aug; 82(2-3):319-34. PubMed ID: 12175746
[TBL] [Abstract][Full Text] [Related]
16. Chlorhexidine controlled-release profile after EDTA root surface etching: an in vivo study.
Gamal AY; Kumper RM; Sadek HS; El Destawy MT
J Periodontol; 2011 May; 82(5):751-7. PubMed ID: 21091349
[TBL] [Abstract][Full Text] [Related]
17. Alginate films augmented with chlorhexidine hexametaphosphate particles provide sustained antimicrobial properties for application in wound care.
Duckworth PF; Maddocks SE; Rahatekar SS; Barbour ME
J Mater Sci Mater Med; 2020 Mar; 31(3):33. PubMed ID: 32162052
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study.
Paolantonio M; D'Angelo M; Grassi RF; Perinetti G; Piccolomini R; Pizzo G; Annunziata M; D'Archivio D; D'Ercole S; Nardi G; Guida L
J Periodontol; 2008 Feb; 79(2):271-82. PubMed ID: 18251641
[TBL] [Abstract][Full Text] [Related]
19. Chlorhexidine hexametaphosphate as a coating for elastomeric ligatures with sustained antimicrobial properties: A laboratory study.
Kamarudin Y; Skeats MK; Ireland AJ; Barbour ME
Am J Orthod Dentofacial Orthop; 2020 Nov; 158(5):e73-e82. PubMed ID: 33008710
[TBL] [Abstract][Full Text] [Related]
20. The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid.
Azmak N; Atilla G; Luoto H; Sorsa T
J Periodontol; 2002 Jun; 73(6):608-15. PubMed ID: 12083533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
